These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 5718780)
41. [Cardiac treatment of out-patients using encordin]. Schütz E Munch Med Wochenschr; 1969 Oct; 111(43):2239-43. PubMed ID: 5395247 [No Abstract] [Full Text] [Related]
42. [Resorption of alpha-acetyldigoxin and beta-acetyldigoxin studied by ECG]. Watzke K; Klepzig H Med Klin; 1972 Mar; 67(12):413-7. PubMed ID: 5022885 [No Abstract] [Full Text] [Related]
43. [Directed glycoside therapy of manifest heart insufficiency]. Storz H Med Klin; 1971 Apr; 66(16):587-92. PubMed ID: 5552925 [No Abstract] [Full Text] [Related]
44. [Therapy of the coronary syndrome and cardiac failure. Experiences with Adenylocrat and Adenylocrat-Digoxin]. Vargha A Munch Med Wochenschr; 1970 Dec; 112(49):2247-51. PubMed ID: 5536817 [No Abstract] [Full Text] [Related]
49. [Quantitative glycoside therapy in medical practice]. Bayer O Dtsch Med J; 1967 Aug; 18(15):458-64. PubMed ID: 5611945 [No Abstract] [Full Text] [Related]
50. [Clinical aspects of mathematical calculation of adequate therapeutic doses of pure cardiac glycosides]. Slutskiĭ ME Sov Med; 1967 Sep; 30(9):20-6. PubMed ID: 5604641 [No Abstract] [Full Text] [Related]
51. [1st clinical experiences with the treatment of heart insufficiency with beta-acetyldigoxin]. Seeberger E Arztl Forsch; 1966 Nov; 20(11):595-600. PubMed ID: 6014838 [No Abstract] [Full Text] [Related]
52. [Note on clinical use of Acygoxine tablets]. Delaage M; Medvedowsky JL Mars Med; 1972; 109(10):659-61. PubMed ID: 4659846 [No Abstract] [Full Text] [Related]
53. [Cardiac glycoside therapy]. Born H Folia Clin Int (Barc); 1969 Nov; 17(11):534-45. PubMed ID: 5803723 [No Abstract] [Full Text] [Related]
54. [The use of pharmacokinetic data for rational digitalization]. Cristodorescu R; Streian C; Deutsch G; Luca C Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(4):333-42. PubMed ID: 6140731 [No Abstract] [Full Text] [Related]
55. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration]. Rosini E; Petacchi R Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292 [No Abstract] [Full Text] [Related]
56. [Cliical aspects of cardiocinetic therapy with a new cardioactive glucoside: acetyldigoxin]. Malaguti P Minerva Cardioangiol; 1968 Mar; 16(3):225-30. PubMed ID: 5740756 [No Abstract] [Full Text] [Related]
57. [Some practical problems of cardiac glycoside therapy]. Szám I Orv Hetil; 1969 Feb; 110(7):366-71. PubMed ID: 5780287 [No Abstract] [Full Text] [Related]
58. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies]. Pagliara R Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717 [No Abstract] [Full Text] [Related]
59. [On a new glycoside with cardiokinetic action]. Poggi F Minerva Med; 1966 May; 57(43 Suppl):2006-11. PubMed ID: 5943260 [No Abstract] [Full Text] [Related]
60. [Initial clinical evaluations of a new cardioactive glycoside, beta-methyldigoxin]. Testoni F; Galante A; Verzelletti L Boll Soc Ital Cardiol; 1973; 18(1):45-52. PubMed ID: 4619969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]